| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $430.9M | $391.5M | $361.4M |
| YoY Revenue Growth % | +10.1% | +8.3% | — |
| Gross Profit | $351.5M | $320.9M | — |
| Gross Margin % | 81.6% | 82.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.2M | -$15.8M | -$15.1M |
| Operating Margin % | -0.3% | -4.0% | -4.2% |
| Net Income (GAAP) | $21.0M | $18.2M | $3.7M |
| EBITDA (Normalized) | -$659.4K | -$14.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $104.6M | $83.1M | $83.2M |
| Capital Expenditures (CapEx) | $647.0K | $1.3M | — |
| Free Cash Flow (FCF) | $103.9M | $81.8M | $83.2M |
| FCF Margin % | 24.1% | 20.9% | 23.0% |
| Return on Invested Capital (ROIC %) | -0.3% | -5.5% | — |
| Cash & Short-Term Equivalents | $125.2M | $133.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $412.0M | $362.6M | — |